Daniela Steinberger

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes

Hao Hu, Stefan A. Haas, Jamel Chelly et al. · Molecular Psychiatry · 2015 · 299 citations · Full text

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium

Cathelijne H. van der Wouden, Anne Cambon‐Thomsen, Erika Cecchin et al. · Clinical Pharmacology & Therapeutics · 2016 · 288 citations · Full text

Relevant Pgx-markers, Genetic Epidemiology, Ubiquitous Pharmacogenomics +22

Latanoprost, a Prostaglandin Analog, for Glaucoma Therapy

Carl B. Camras, Albert Alm, Peter Watson et al. · Ophthalmology · 1996 · 238 citations

Ocular Disease, Ophthalmology, Medicine +5

S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma.

Vivienne C. Greenstein, Donald C. Hood, Robert Ritch et al. · PubMed · 1989 · 185 citations

Sensitivity Loss, Retinal Diseases, Diabetic Retinopathy +15